Facilitating the implementation of pharmacokinetic-guided dosing of prophylaxis in haemophilia care by discrete choice experiment

Introduction Patients’, parents’ and providers’ preferences with regard to medical innovations may have a major impact on their implementation. Aim To evaluate barriers and facilitators for individualized pharmacokinetic (PK)‐guided dosing of prophylaxis in haemophilia patients, parents of young pat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haemophilia : the official journal of the World Federation of Hemophilia 2016-01, Vol.22 (1), p.e1-e10
Hauptverfasser:	Lock, J., de Bekker-Grob, E. W., Urhan, G., Peters, M., Meijer, K., Brons, P., van der Meer, F. J. M., Driessens, M. H. E., Collins, P. W., Fijnvandraat, K., Leebeek, F. W. G., Cnossen, M. H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Choice Behavior discrete choice experiment Drug Dosage Calculations Female haemophilia Hemophilia A - prevention & control Humans implementation Male Middle Aged Models, Statistical pharmacokinetic-guided dosing preferences prophylaxis Surveys and Questionnaires Tissue Distribution Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!